The US Affiliate of a top 10 European based pharma company came to the realization that their clinical development sourcing model had evolved within its late stage clinical operations function. In this model a blended approach to sourcing with reliance on insourcing, full service outsourcing, and functional service provider (FSP) approaches were all used based on study team decisions rather than overarching organizational strategy. Furthermore, the company did not possess a standardized approach to compare and contrast different sourcing models to allow objective performance benchmarking.